| 恩替卡韦联合胸腺肽肠溶片治疗慢性乙肝的疗效及安全性评价 |
| |
| 引用本文： | 严金柱,孙艺萍.恩替卡韦联合胸腺肽肠溶片治疗慢性乙肝的疗效及安全性评价[J].中国实用医药,2013,8(14):61-62. |
| |
| 作者姓名： | 严金柱 孙艺萍 |
| |
| 作者单位： | 严金柱 (英德市人民医院,513000)； 孙艺萍 (英德市人民医院,513000)； |
| |
| 摘 要： | 目的探讨恩替卡韦联合胸腺肽肠溶片治疗慢性乙肝的疗效。方法 90例慢性乙肝患者,分成观察组和对照组。对照组给予恩替卡韦治疗,观察组给予恩替卡韦联合胸腺肽肠溶片治疗。结果观察组总有效率82.22%高于对照组62.22%,差异有统计学意义（P〈0.05）。结论恩替卡韦联合胸腺肽肠溶片治疗慢性乙肝疗效较佳,具有良好的安全性。
|
| 关 键 词： | 恩替卡韦 胸腺肽肠溶片 慢性乙肝 |
Evaluation of efficacy and safety of entecavir combined with thymosin enteric-coated tablets in the treatment of chronic hepatitis B |
| |
| YAN Jin-zhu,SUN Yi-ping.Evaluation of efficacy and safety of entecavir combined with thymosin enteric-coated tablets in the treatment of chronic hepatitis B[J].China Practical Medical,2013,8(14):61-62. |
| |
| Authors: | YAN Jin-zhu SUN Yi-ping |
| |
| Institution: | .The people’s Hospital of Yingde City,Qingyuan,Guangdong 513000,China |
| |
| Abstract: | Objective To investigate the efficacy of entecavir combined with thymosin enteric-coated tablets in the treatment of chronic hepatitis B.Methods 90 cases of chronic hepatitis B patients,divided into the observation group and the control group.The control group was given entecavir,observation group were treated with entecavir combined with thymosin enteric-coated tablets.Results The observation group the total effective rate was 82.22% higher than 62.22% in the control group,significant difference（P＆lt;0.05）.Conclusion Entecavir combined with thymosin enteric-coated tablets in the treatment of chronic hepatitis B is better,has a good safety. |
| |
| Keywords: | Entecavir Thymosin enteric-coated tablets Chronic hepatitis B |
| 本文献已被 维普 等数据库收录！ |
|
